Evotec SE (EVO) Cash from Investing Activities (QoQ) (2009 - 2026)
Evotec SE (EVO) Cash from Investing Activities (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Evotec SE | 692.56 Mn | 692.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -100.01% |
| Dec 31, 2025 | 2,360,353.92% |
| Sep 30, 2025 | 65.92% |
| Jun 30, 2025 | -9.29% |
| Mar 31, 2025 | 99.97% |
| Dec 31, 2024 | -266,812.39% |
| Sep 30, 2024 | 15.50% |
| Jun 30, 2024 | -0.33% |
| Mar 31, 2024 | 99.77% |
| Dec 31, 2023 | -108,764.93% |
| Sep 30, 2023 | -150.04% |
| Jun 30, 2023 | 426.20% |
| Mar 31, 2023 | 100.00% |
| Dec 31, 2022 | -182,766.23% |
| Sep 30, 2022 | -94.02% |
| Jun 30, 2022 | -10.36% |
| Mar 31, 2022 | 99.96% |
| Dec 31, 2021 | -468,777.97% |
| Sep 30, 2021 | -48.98% |
| Jun 30, 2021 | 207,278.57% |